- Home
- ORIC vs TKNO Comparison
ORIC vs TKNO Comparison
Compare ORIC & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- TKNO
- Stock Information
- Founded
- ORIC 2014
- TKNO 1996
- Country
- ORIC United States
- TKNO United States
- Employees
- ORIC N/A
- TKNO N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- ORIC Health Care
- TKNO Health Care
- Exchange
- ORIC Nasdaq
- TKNO Nasdaq
- Market Cap
- ORIC 362.9M
- TKNO 356.4M
- IPO Year
- ORIC 2020
- TKNO 2021
- Fundamental
- Price
- ORIC $8.17
- TKNO $5.77
- Analyst Decision
- ORIC Strong Buy
- TKNO Buy
- Analyst Count
- ORIC 8
- TKNO 1
- Target Price
- ORIC $18.83
- TKNO $5.00
- AVG Volume (30 Days)
- ORIC 1.6M
- TKNO 426.7K
- Earning Date
- ORIC 05-05-2025
- TKNO 05-08-2025
- Dividend Yield
- ORIC N/A
- TKNO N/A
- EPS Growth
- ORIC N/A
- TKNO N/A
- EPS
- ORIC N/A
- TKNO N/A
- Revenue
- ORIC N/A
- TKNO $38,250,000.00
- Revenue This Year
- ORIC N/A
- TKNO $8.73
- Revenue Next Year
- ORIC N/A
- TKNO $16.53
- P/E Ratio
- ORIC N/A
- TKNO N/A
- Revenue Growth
- ORIC N/A
- TKNO 3.79
- 52 Week Low
- ORIC $3.90
- TKNO $1.16
- 52 Week High
- ORIC $14.67
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- ORIC 72.38
- TKNO 40.65
- Support Level
- ORIC $5.52
- TKNO $5.68
- Resistance Level
- ORIC $8.44
- TKNO $6.01
- Average True Range (ATR)
- ORIC 0.63
- TKNO 0.42
- MACD
- ORIC 0.32
- TKNO -0.11
- Stochastic Oscillator
- ORIC 93.11
- TKNO 7.58
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.